| HOME >> BIOLOGY >> TECHNOLOGY |
7,6239,504Total liabilities
$
2,968$
9,030Commitments and ContingenciesRedeemable Convertible Preferred Shares
-94,514Shareholders' Equity (Deficit)Common shares; 100,000,000 shares authorized, no par value;533,839 shares issued and outstanding at December 31, 2011 andnone issued and outstanding at December 31, 2012
--Common stock; $.001 par value; none issued and outstanding atDecember 31, 2011 and 80,000,000 shares authorized; 24,903,774shares issued and outstanding at December 31, 2012
25-Additional paid-in capital
178,971-Deficit accumulated during the development stage
(121,226)(96,685)Total shareholders' equity (deficit)
57,770(96,685)Total liabilities, redeemable convertible preferred sharesand shareholders' equity (deficit)
$
70,738$
,859Condensed Consolidated Statements of Operations(unaudited; in thousands, except loss per share data)Three Months Ended December 31,20122011Revenues
$ -
$ -Operating expensesResearch and development
4,4131,458General and administrative
1,8251,057T
'/>"/>SOURCE Cempra, Inc.
Copyright©2012 PR Newswire.
All rights reserved
Related biology technology :
1. United States Patent and Trademark Office to Require Signed NDA Affects Many Reports Wysebridge
2. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
3. Soligenix Reports Year-End 2012 Financial Results and Highlights Recent Accomplishments
4. InterMune Reports Fourth Quarter And Full Year 2012 Financial Results And Business Highlights
5. Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
6. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on February 14, 2013
7. Neuland Labs Reports Third Quarter Fiscal Year 2013 Financial Results
8. Intraocular Lens (IOL) Market Worth $3.8 Billion By 2018 Say New Research Report at ReportsnReports.com
9. Regenerative Medicine and Stem Cells Market Deals Analysis in New Research Report at ReportsnReports.com
10. Cellular Therapy Market and Cord Blood Market 2013 Industry Research Report: MarketResearchReports.Biz
11. Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results